Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.16B |
| 2 |
Bank of America
BAC
|
+$855M |
| 3 |
Comcast
CMCSA
|
+$620M |
| 4 |
Amazon
AMZN
|
+$505M |
| 5 |
Micron Technology
MU
|
+$486M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$441M |
| 2 |
Palo Alto Networks
PANW
|
+$300M |
| 3 |
Verizon
VZ
|
+$286M |
| 4 |
Fidelity National Information Services
FIS
|
+$285M |
| 5 |
Stanley Black & Decker
SWK
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Financials | 6.16% |
| 3 | Industrials | 5.09% |
| 4 | Consumer Discretionary | 4.89% |
| 5 | Healthcare | 4.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
LyondellBasell Industries
LYB
$20.6B
| $4.27M | ﹤0.01% |
38,732
+7,890
| +26% | +$818K |
|
2527
Eastman Chemical
EMN
$8.47B
| $4.26M | ﹤0.01% |
46,007
+10,397
| +29% | +$945K |
|
|
MLNX
2528
CALL
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $4.26M | ﹤0.01% |
65,800
+22,100
| +51% | +$1.17M |
|
|
SWN
2529
PUT
DELISTED
Southwestern Energy Company
SWN
| $4.25M | ﹤0.01% |
762,300
+435,800
| +133% | +$2.53M |
|
2530
Silicon Laboratories
SLAB
$7.29B
| $4.25M | ﹤0.01% |
48,143
+11,565
| +32% | +$1.04M |
|
2531
PUT
Vanguard FTSE Europe ETF
VGK
$31.1B
| $4.25M | ﹤0.01% |
71,800
-7,100
| -9% | -$414K |
|
2532
Insperity
NSP
$1.99B
| $4.24M | ﹤0.01% |
73,928
+18,300
| +33% | +$969K |
|
2533
Kulicke & Soffa
KLIC
$5.19B
| $4.24M | ﹤0.01% |
174,188
-3,508
| -2% | -$83.6K |
|
2534
Prestige Consumer Healthcare
PBH
$2.43B
| $4.23M | ﹤0.01% |
95,302
+89,133
| +1,445% | +$4.06M |
|
|
CAA
2535
DELISTED
CalAtlantic Group, Inc.
CAA
| $4.23M | ﹤0.01% |
75,000
-350,825
| -82% | -$17.1M |
|
2536
GATX Corp
GATX
$6.38B
| $4.23M | ﹤0.01% |
67,983
-24,867
| -27% | -$1.51M |
|
2537
John Wiley & Sons Class A
WLY
$2.61B
| $4.23M | ﹤0.01% |
64,279
-33,379
| -34% | -$1.93M |
|
2538
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.56B
| $4.22M | ﹤0.01% |
103,755
-204,119
| -66% | -$8.4M |
|
2539
The GEO Group
GEO
$4.11B
| $4.22M | ﹤0.01% |
+178,907
| New | +$4.55M |
|
|
PPL
2540
PUT
PPL Corp
PPL
$27.1B
| $4.22M | ﹤0.01% |
136,300
+96,500
| +242% | +$3.47M |
|
|
SUP
2541
DELISTED
Superior Industries International
SUP
| $4.22M | ﹤0.01% |
283,988
-4,413
| -2% | -$70.5K |
|
|
DVAX
2542
DELISTED
Dynavax Technologies
DVAX
| $4.21M | ﹤0.01% |
225,299
-903,262
| -80% | -$18.1M |
|
2543
iShares Global Consumer Staples ETF
KXI
$1.07B
| $4.21M | ﹤0.01% |
79,534
+56,348
| +243% | +$2.92M |
|
2544
SM Energy
SM
$8.03B
| $4.21M | ﹤0.01% |
190,798
-2,422,508
| -93% | -$48.9M |
|
2545
PUT
Idexx Laboratories
IDXX
$43.4B
| $4.21M | ﹤0.01% |
26,900
+15,300
| +132% | +$2.41M |
|
2546
NVIDIA
NVDA
$5.45T
| $4.21M | ﹤0.01% |
869,320
-11,273,760
| -93% | -$56M |
|
2547
Woodward
WWD
$21.9B
| $4.21M | ﹤0.01% |
+54,940
| New | +$4.29M |
|
2548
FerroAtlántica
GSM
$820M
| $4.2M | ﹤0.01% |
259,365
-58,283
| -18% | -$903K |
|
2549
Upbound Group
UPBD
$1.14B
| $4.2M | ﹤0.01% |
+377,947
| New | +$4.14M |
|
|
ENV
2550
DELISTED
ENVESTNET, INC.
ENV
| $4.19M | ﹤0.01% |
84,076
+28,707
| +52% | +$1.49M |
|
Similar funds
Ken Griffin's Q4 2017 Portfolio in Review
As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.
- Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
- Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
- Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
- Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.
Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.